Eledon Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Eledon Pharmaceuticals

10/08/2023 14:02

* Eledon Pharmaceuticals Inc  ELDN.OQ  reported a quarterly
adjusted loss of 40 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 46 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Eledon Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 40 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Eledon Pharmaceuticals Inc shares had fallen by 11.7% this
quarter and lost 46.9% so far this year.
    * The company reported a quarterly loss of $9.58 million.
    * Wall Street's median 12-month price target for Eledon
Pharmaceuticals Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 01:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.46          -0.40          Beat
 Mar. 31 2023      -0.60          -0.75          Missed
 Dec. 31 2022      -0.70          -0.69          Beat
 Sep. 30 2022      -0.68          -0.73          Missed